Healthcare IT Integration Market Rapidly Growth with Top Global Leader During the Forecast Period, 2013-2023

Healthcare IT integration is a consortium of IT and healthcare sector and involves the application of latest IT solutions to monitor people’s health, perform secured exchange of their electronic data and provide economical healthcare solutions.

The major factors that will accelerate the growth of the healthcare IT integration market are high healthcare costs, government initiatives to curb this rising cost and the growing demand to incorporate IT in the healthcare domain. However, the cost of incorporation is expensive and needs to monitored for the growth in the global market.

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/healthcare-it-integration-market/report-sample

The players in the global market are focusing to launch products with technological advancements which is causing rapid growth of the market. Another key factor that drives the growth of the healthcare IT integration market is the integration of healthcare industry with information technology and application of IoT (Internet of Things) to curb the overall healthcare cost. The government organizations have been providing their support and taking initiatives for the growth of the healthcare integration market size.

Globally, North America leads the healthcare IT integration market followed by Europe. The reasons for the growth of North America healthcare IT integration industry are technologically advanced environment in the region, increased government intervention to provide better healthcare facilities and favorable reimbursement policies that aid in lowering the rising healthcare cost and the growing demand of integrating IT into the healthcare system.

Asia-Pacific is expected to be the fastest growing healthcare IT integration market in the forecast period. The rise in awareness with respect to various health conditions and the consequent increase in expenditure for a better healthcare infrastructure, thereby providing quality healthcare facilities at lower cost are some of the drivers for the region’s fastest growth.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=healthcare-it-integration-market

key players in the global healthcare IT integration market are Quality Systems Inc., Allscripts Healthcare Solutions, Inc., Orion Health, Oracle Corporation, Qualcomm Life, Inc., IBM Corporation, Corepoint Health LLC, GE Healthcare, Siemens Health, Epic Systems Corporation, Summit Healthcare Services, Inc.

Medical Image Management Market Business Overview, Challenges, Opportunities, Trends and Market Analysis by 2023

The global medical image management market is witnessing considerable growth due to technological advancements in diagnostic imaging modalities and image management solutions, increasing usage of imaging equipment, and increasing adoption of Vendor Neutral Archive (VNA). Moreover, increasing investment in the medical imaging, increasing adoption of imaging management system by small imaging centers and hospitals, and rapidly growing big data in healthcare are supporting the demand for medical image management systems. The increasing government initiatives to encourage electronic medical record adoption is further expected to boost the market. 

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/medical-image-management-market/report-sample

Hospitals have been the largest user of medical image management systems, owing to growing awareness about early diagnosis of diseases, increasing digitalization of patient’s data, rapid growth in adoption of EMR, and technological advancement in imaging modalities.

Geographically, North America has been the largest market for medical image management, owing to increasing geriatric population, and increasing prevalence of various diseases such as cancer and cardiovascular disease in the region.

Globally, the medical image management market is expected to witness the fastest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to the increasing geriatric population, large pool of patients, and increasing prevalence of various diseases in the region.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=medical-image-management-market

The key players operating in the global medical image management market are McKesson Corporation, General Electric Company, Fujifilm Holdings Corporation, Siemens AG, IBM Corporation, Koninklijke Philips N.V. and AGFA-Gevaert Group.

Health IT Security Market Competitive Scenario of the Market, Major Competitors, Market Share, Benchmarking, Investments and Merger Acquisitions

The global health IT security market is witnessing considerable growth due to stringent regulatory requirements and interconnected medical devices. Since the usage of interconnected medical device is continuously increasing, health IT security would play a major role in the safety of health information assembled and imparted from various smart devices to patients and care givers. Moreover, increasing use of mobile device, due to greater adoption of bring-your-own device policy, is supporting the growth of the market. 

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/health-it-security-market/report-sample

Information privacy and patient privacy are the major aspects of the well-functioning of healthcare environment. Cyber-attacks are increasing constantly around the globe. Hospital encounters major concern due to abundant cyber-attacks that impend the secrecy and safety of their data assets and enterprise IT systems.

The cloud security proposes new growth avenues of health IT security, and evolution of next generation IT security solution is expected to create opportunities for the market. In addition, massive unexplored market in developing economies are creating abundant opportunities for the health IT security market to grow at a significant rate in the coming years. However, limited cyber security professionals and limited spending on IT security are the key factors hampering the growth of the global market.

Geographically, North America has been the largest market for health IT security, owing to large number of healthcare data breeches, and stringent regulatory requirements on data privacy in the region. The U.S. contributed largest revenue to the North American as well as global health IT security market. Europe has been the second largest market for health IT security, where the market is driven by the increasing number of cyber-attacks to misuse healthcare information of an individual. Globally, the health IT security market is expected to witness the fastest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to the increasing awareness of IT security and increasing adoption of connected medical devices for managing increasing prevalence of chronic illness in the region.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=health-it-security-market 

The key players operating in the global market are IBM Corporation, Symantec Corporation, Trend Micro Incorporated, Oracle Corporation, EMC Corporation, SailPoint Technologies, Dell Inc., Hewlett Packard, AT&T, and Intel Corporation.

Cancer Gene Therapy Market by Therapy, End User and Geography: Global Research Report, 2013-2023

The global cancer gene therapy market is expected to attain lucrative growth in the forecast period mainly due to rise in funding for R&D activities for cancer gene therapy, increasing prevalence of cancer, and rapid technological advancements being witnessed in the market. Gene therapy is used for the treatment of cancer, where a functional gene is inserted into the cells of a patient to correct a genetic abnormality and provide new function to the cells.

Gene transfer therapies holds the largest share in the global market and the category is also expected to witness fastest growth in demand during the forecast period. The key end users in the cancer gene therapy market include hospitals, oncology institutes, biotechnological companies and clinical research laboratories.

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/cancer-gene-therapy-market/report-sample

According to the American Cancer Society (ACS), around 1,688,780 new cancer cases are expected to be diagnosed, in the U.S., in 2017. Almost, 600,920 Americans are expected to die of cancer in 2017, indicating that around 1,650 cancer patients are dying per day, due to the disease. In 2013, the World Health Organization (WHO) launched the Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020, that aimed at reducing the rate of premature mortality from cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases by 25%, by 2025.

North America is expected to lead the global cancer gene therapy market throughout the forecast period (2018–2023) followed by the Europe. This is mainly due to strong healthcare infrastructure and high expenditure in R&D in North America. 

Additionally, emerging countries, such as India, and Korea, are characterized by a huge patient pool, which can be attributed to the increasing burden of non-communicable diseases and rising geriatric population in these countries. According to the WHO, chronic diseases are estimated to increase by 57% by 2020, globally.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=cancer-gene-therapy-market

The players in the global market have been receiving approvals for the cancer gene therapy treatments to provide better treatment to cancer patients, thus increasing their market share. For instance, in December 2017, Celgene Corporation and bluebird bio, Inc. announced the updated results from the ongoing CRB-401 Phase 1 clinical study of bb2121, an investigational anti-B-cell maturation antigen (BCMA) CAR T cell therapy, in 21 patients suffering with late-stage relapsed/refractory multiple myeloma.

Europe Sleeping Aids Market by Sleep Disorder, Product and Geography | Global Research Report, 2012-2022

The European sleeping aids market was valued at $14.8 billion in 2015 and is forecasted to grow at a CAGR of 6.2% during 2016-2022.

Various sleep disorders are hampering the lives of people in the region, due to increasing tobacco and alcohol consumption, rising aging population, growing population base working in night shifts and changing lifestyle habits of the Europeans. Sleep disorders such as insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleep walking and others greatly affect the population base in the European region.

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/europe-sleeping-aids-market/report-sample

Sleeping aids namely mattress & pillow, sleep laboratories, medication, sleep apnea devices and others are largely used for the above-mentioned sleeping disorders. Mattress & pillows held the largest share in the European sleeping aids market and contributed 43% in 2015. Amongst all the sleep related problems people are being majorly affected by insomnia and sleep apnea in the Europe.

Explore Full Report@ https://www.psmarketresearch.com/market-analysis/europe-sleeping-aids-market

According to the Eurostat, aging population is a long-term trend in the region, this is also a key factor driving the demand for sleeping aids in the region. The share of population aged 65 years and over is increasing in every European Union (EU) member state. During the period 2016 to 2080 the aging population is expected to account for a share of 29.1% of the EU-28 population compared to 19.2% in 2016.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=europe-sleeping-aids-market

Some of the key players operating in the European sleeping aids industry are Sanofi S.A., Koninklijke Philips N.V., GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Roche Holding AG, AstraZeneca plc, Becton, Dickinson and Company, Drive Medical Ltd., Somnomedics Gmbh and Cardinal Health.

Urinalysis Market by Demand, Growth Rate and Forecast, 2023

The global urinalysis market is witnessing considerable growth due to increasing prevalence of diabetes, increasing geriatric population, increasing prevalence of kidney diseases and growing urinary tract infections (UTI).

Increase in diabetic cases leads to increased sales of urinalysis dipsticks, disposables and devices across the globe. For instance, according to the World Health Organization (WHO) the global diabetes prevalence has increased from 4.7% to 8.5% from 1980 to 2014, respectively. As per International Diabetes Federation (IDF), Western Pacific (WP) region consists of maximum diabetes cases; its prevalence was 138 million cases in 2014, which is expected to reach 202 million in 2035. Similarly, according to IDF, the prevalence of diabetes in South-East Asia (SEA) is expected to increase from 75 million in 2014 to 123 million in 2035.

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/urinalysis-market/report-sample

Geographically, North America has been the largest market for urinalysis, owing to increased awareness, growth of aged pool, established healthcare industry, and easy accessibility to advanced technologies. 

Globally, the urinalysis market in Asia-Pacific would witness highest growth during the forecast period. The highest growth in the region is attributed to the increasing prevalence of kidney diseases, increasing per capita income leading to improved standard of living, increasing healthcare spending, growing demand for better quality medical care, and awareness about urinalysis tests in the region. In addition, increasing demand for pregnancy test further drives the market growth in the region.

Make a Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=urinalysis-market

The key players operating in the global urinalysis market are F. Hoffmann-LA Roche AG, Danaher Corporation, Siemens AG, Sysmex Corporation, Bio-Rad Laboratories, Inc., Mindray Medical International Limited, Acon Laboratories, Inc., Arkray, Inc. and Urit Medical Electronic Group Co., Ltd.

Healthcare Contract Research Organization Market :Global Outlook of Opportunities 2023

The increasing R&D investments from pharmaceutical companies and extensive drug pipelines for the treatment of various chronic diseases, such as immunological disorders, metabolic disorders, and neurological disorders, are the predominant growth drivers for the global healthcare contract research organization (CRO) market. 

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/contract-research-organization-market/report-sample

CROs provide support and services in form of research facilities outsourced on contract basis to life sciences, pharmaceutical, and medical device industries. The major services offered by CROs include preclinical research, biologic assay development, biopharmaceutical and pharmaceutical development, commercialization, clinical trials management, and clinical research. These organizations also provide support to research organizations, academic institutes, and government organizations.

Full Explore Report@ https://www.psmarketresearch.com/market-analysis/contract-research-organization-market

North America and Europe are the major markets, due to increasing prevalence of chronic diseases, and improved research infrastructure in these regions. The U.S. followed by Canada, is the largest market for healthcare CRO in North America. Whereas, the U.K., Germany, and France are some of the major countries holding significant share in the European market.

The Asian market is growing with a significant rate, owing to increasing prevalence of chronic diseases, and growing demand of innovative and advanced pharmaceutical and biopharmaceutical products in the region. In addition, the low R&D costs, and increasing investments by several pharmaceutical and biopharmaceutical drugs manufacturing companies are also supporting the growth of the Asian Healthcare CRO market. The countries, such as India, Japan, and China, are the major markets in the region.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=contract-research-organization-market

Some of the major players operating in the global healthcare CRO market include Laboratory Corporation of America Holdings, Quintiles IMS Holdings, Inc., PAREXEL International Corporation, Charles River Laboratories, Inc., Pharmaceutical Product Development, LLC, ICON plc, PRA Health Sciences, and inVentiv Health, Inc.

Smoking Cessation Market | Current Market Status, Emerging Trend and Global Future Forecast by 2023

The global smoking cessation market is growing due to growing awareness about health problems associated with smoking and growing acceptance rate of smoking cessation products. On the basis of products, the electronic cigarette segment is expected to grow with the fastest rate during the forecasted period. 

Nicotine gums led the nicotine replacement therapy market; however, the nicotine lozenges are expected to grow with the fastest rate during the projected period. The innovation of products with better efficacy is also expected to pose as an opportunity for growth of the market.

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/smoking-cessation-market/report-sample

Smoking cessation is the process of discontinuing tobacco smoking and it helps to reduce the risk of smoking related diseases. Nicotine withdrawal symptoms may include feeling hungrier than usual, having trouble thinking, craving for tobacco products, and feeling irritable, anxious and angry. According to the Centre for Disease Control and Prevention in 2010, approximately 7 out of every 10 adult cigarette smokers wanted to quit smoking completely.

Some of the factors driving the growth of the global smoking cessation market are increasing number of smokers, stringent laws for smoking such as ban on smoking in public place, increasing government initiatives by distribution of smoking cessation products and higher taxes on tobacco products.

Geographically, North America is expected to dominate the global market in the coming years, due to increasing number of smokers and growing awareness regarding health hazards associated with smoking. Asia-Pacific is expected to be the fastest growing region for the market, due to increasing awareness about the smoking cessation products and large pool of patients in the region. In addition, the Asia-Pacific market is growing due to increasing prevalence of health complications associated with smoking in the emerging countries, such as India and China.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=smoking-cessation-market

Some of the companies operating in the global smoking cessation market are Johnson & Johnson, GlaxoSmithKline, Njoy Inc., Nicotek LLC, VMR Products LLC, British American Tobacco PLC, Reynolds American Inc., Perrigo, Pfizer, and Novartis.

Artificial Intelligence in Healthcare Market: Technology Growth by Top Global Leader - Intel, Nvidia, Google, IBM, Microsoft, General Vision, Enlitic and Others

The global artificial intelligence in healthcare market is expected to observe an extensive growth in the coming years, led by growing need for precision medicine, increasing application of big data in healthcare industry, and rising need for coordination between healthcare workforce and patients.

The products in the global market are categorized as hardware, software and services, with software being the largest contributor in 2016 and the category is also projected to witness significant growth during the forecast period. Growing number of software companies and increasing demand of software based AI solutions are the key factors driving the growth of this product category.

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/artificial-intelligence-in-healthcare-market/report-sample

Deep learning, natural language processing (NLP), querying method and context aware processing are some of the technologies used for AI in healthcare. The demand for NLP in healthcare has been growing mainly due to rise in unstructured clinical data. Since NLP technology extracts important clinical information from unstructured data and analyze it for enhancing processing and analytics

North America leads the global market due to presence of major AI providers including Intel Corporation, Google, Inc., IBM Corporation in the region.

Asia-Pacific is expected to witness the fastest growth during the forecast period. Increasing healthcare expenditure, continuously improving healthcare infrastructure due to growing medical tourism and growing aging population are the factors expected to support the growth of the Asia-Pacific AI in healthcare market.

The key factors that drive the growth of the industry include rise in need for coordination between healthcare workforce and patients, increasing application of Big Data in healthcare industry, ability of AI to improve patient outcomes, growing demand for precision medicine and increase in venture capital investments.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=artificial-intelligence-in-healthcare-market

Key players in the global AI in healthcare market include Intel Corporation, IBM Corporation, Microsoft Corporation, Google, Inc., General Electric Company, NVIDIA Corporation, Medtronic Plc, Koninklijke Philips N.V., iCarbonX, Next IT Corp., Welltok, Inc., General Vision, Inc, Recursion Pharmaceuticals, Enlitic, Inc. Stryker Corporation, Deep Genomics, Inc., and Oncora Medical, Inc.

Hospital Infection Therapeutics Market Segmentation, Emerging Opportunities, Major Competitors and Porter Analysis

The hospital infection therapeutics market is increasing at a significant rate, due to high susceptibility of neonatal population in healthcare setting and high occurrence of numerous hospital infections. Increasing incidences of hospital infections, high number of pipeline drug molecules for specific treatment of healthcare associated infections and high unaddressed needs in most of the countries are some of the factors providing ample opportunities for the hospital infection therapeutics market to grow in the coming years.

North America leads the hospital infection therapeutics market followed by Europe. The North America hospital infection therapeutics market leads, due to improved healthcare awareness, high ratio of hospitals as compared to population of the region, increasing count of multi drug resistant microbial pathogens and increase in aging population of the region. Asia-Pacific is growing with an exponential rate, due to increased incidences of hospital infections and high demands of therapeutic drugs in the emerging countries such India and China.

Request to get the Sample Report@ https://www.psmarketresearch.com/market-analysis/hospital-infection-therapeutics-market/report-sample

The hospital infection therapeutics market can be categorized on the basis of drug type into, antifungal drugs, antibacterial drugs and antiviral drugs. Antibacterial drug leads the global hospital infection therapeutics market and is also expected to grow at the highest rate in coming years among the drug types in hospital infection therapeutics market.

On the basis of infection types, the hospital infection therapeutics market can be categorized into hospital acquired pneumonia, urinary tract infections, bloodstream infections, surgical site infections and gastrointestinal disorders. Hospital acquired pneumonia leads the global hospital infection therapeutics market, under the types of infection categories. While urinary tract infections are expected to grow at an exponential rate in the coming years.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=hospital-infection-therapeutics-market

Some of the competitors in the hospital infection therapeutics market are: Cubist Pharmaceuticals, Inc., Actavis PLC, Johnson & Johnson Services, Inc., Bayer AG, GlaxoSmithKline PLC, Bristol-Myers Squibb Company, Merck & Co., Inc., AstraZeneca PLC, Pfizer, Inc. and Sanofi.

Clinical Laboratory Services Market: Current Market Trends, Industry Vision, Qualitative Analysis, Competitive Landscape & Forecast 2023

The global clinical laboratory services market is growing significantly due to the advances in diagnostic techniques, increasing incidences of chronic diseases, and increasing geriatric population. Healthcare providers’ compliance for clinical diagnostic services is increasing due to the increasing demand for reducing hospitalization time and hospital readmission rates. This in turn propels the growth of the global clinical laboratory services market.

Clinical laboratory services provide information to the healthcare providers for the diagnosis, prevention and treatment of diseases. Clinical laboratory services utilizes several diagnostic procedures and instruments to gather, interpret, and analyze the information from human body specimens, such as blood and urine. Clinical laboratory services have applications in various diagnostic tests, such as nucleic acid tests, pregnancy tests, HIV tests, and test for checking cholesterol level and the test have strong impact on the health outcome. Technological advancements have made diagnostic procedures easy, accurate, and less time consuming, and ultimately improving health outcomes.

Request to get the Sample Report@ https://www.psmarketresearch.com/market-analysis/clinical-laboratory-services-market/report-sample

Some of the factors driving the growth of the global clinical laboratory services market are advances in diagnostic techniques, increasing geriatric population, increasing healthcare providers’ compliance for diagnostic test and services, and increasing investment by big biopharmaceutical companies in the clinical laboratory services market. In addition, increasing prevalence of chronic diseases and increasing healthcare expenditure are supporting the growth of the global clinical laboratory services market.

Geographically, North America leads the global clinical laboratory services market due to high healthcare expenditure, high proportion of geriatric population, and high healthcare providers’ compliance for clinical laboratory services instruments. The high prevalence of chronic diseases also fuels the growth of the global clinical laboratory services market. 

Asia-Pacific is the fastest growing region in the global clinical laboratory services market. The major reasons for the fastest growth in the region are increasing healthcare expenditure, increasing geriatric population, and improving healthcare infrastructure. Moreover, the clinical laboratory services market is growing rapidly due to the increasing prevalence of chronic diseases and increasing investment by pharmaceutical companies in clinical laboratory services market in emerging economies, such as India and China.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=clinical-laboratory-services-market

Some of the major players operating in the global clinical laboratory services market are ARUP Laboratories, Abbott Laboratories, Bio-Reference Laboratories, Charles River Laboratories, Bioscientia Healthcare, Genoptix Medical Laboratory, Healthscope Ltd, Laboratory Corporation Of America Holdings, Labco S.A., Quest Diagnostics Inc., Spectra Laboratories, Sonic Healthcare Limited, and Genoptix Medical Laboratory.

Tumor Ablation Market Outlook: Market Segments, Products, End User and Technology

The global tumor ablation market is growing considerably, due to increasing awareness of ablation procedure over other surgical and conventional procedures, and increasing demand for minimally invasive cancer treatment procedure. The increasing investment in research and development to introduce novel therapies, such as chemo therapy and radiation therapy, are creating opportunities for the global tumor ablation market.

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/tumor-ablation-market/report-sample

Some of the factors driving the growth of the global tumor ablation market are growing geriatric population, increasing number of cancer cases, growing number of hospitals, ablation and surgical centers, low procedural cost associated with radiofrequency ablation tumor and technological advancement in ablation devices. In addition, the upsurge in the healthcare expenditure, increasing healthcare awareness, growing government support and up surging awareness for personalized drugs are expected to drive the growth of the global tumor ablation market.

Geographically, North America is likely to dominate the global tumor ablation market in the coming years, due to high adoption of tumor ablation products and increasing demand for minimally invasive surgeries. However, the ongoing healthcare reforms in the U.S. are inhibiting the growth of North America tumor ablation market. Asia-Pacific is the fastest growing region in the global tumor ablation market, due to presence of huge pool of patients, intensifying government support, and increasing prevalence of cancer in the region. In addition, the tumor ablation Asia-Pacific market is growing, due to increasing healthcare expenditure and refining healthcare infrastructure in the emerging countries, such as India and China.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=tumor-ablation-market

Some of the companies operating in the global tumor ablation market are Mermaid Medical A/S, Medtronic PLC, Boston Scientific Corporation, HealthTronics Inc., CONMED Corporation, EDAP TMS S.A., AngioDynamics Inc., Galil Medical Inc., Misonix Inc., Neuwave Medical Inc., Smith & Nephew PLC and Sonacare Medical LLC.

Global Research Report on Medical Claims Management Solutions Market and their Impact on Global Industry, 2013- 2023

The medical claims management solutions market is segmented on the basis of product, deployment, component and geography. Based on product, the global industry is further divided into standalone claim management system and integrated claim management system.

Based on deployment the market is further divided into cloud based, web based and on-premise based deployments. Since the web-based deployment accounts for a variety of claims systems, it holds the largest share in the global market.

On the basis of component, the medical claims management solutions market is divided into services, hardware, and software. Software is the highest revenue contributor to the medical claims management solutions market, owing to increasing adoption of advanced claims management software by healthcare payers to facilitate easy, accurate, and faster processing of claims.

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/medical-claims-management-solutions-market/report-sample

According to the National Health Insurer Report Card published in 2011 by American Medical Association (AMA), around $17 billion a year (on an average) could be saved by eliminating errors in claims. Automation reduces the paper storage and document retrieval costs while complying with regulatory standards such as Health Insurance Portability and Accountability Act (HIPAA). Health insurance payers invest in their claims management systems to gain interoperability and faster release of new insurance claims, in addition to, improving efficiency of claims processing.

North America and Europe together hold a significant share of the medical claims management solutions market, due to the increased use of software and hardware for processing claims and presence of top insurance companies in these regions. The North American medical claims management solutions market size accounted for the largest share of the global market in 2016, and is expected to maintain its position during the forecast period (2017-2023).

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=medical-claims-management-solutions-market

The major players in the medical claims management solutions market include IBM Corporation, Cerner Corporation, Oracle Corporation, Avaya Inc., Genpact Limited, Cognizant Technology Solutions Corporation, Accenture PLC, Allscripts Healthcare Solutions, Inc., Athenahealth Inc., Aspect Software Inc., and Infor Inc.

Medical Device Connectivity Market Overview with Qualitative Analysis, Competitive Landscape & Forecast 2023

The global medical device connectivity market is witnessing considerable growth due to increasing implementation of electronic health records and health information exchange systems, increasing regulations for improving healthcare quality, growing demand for home healthcare due to increasing geriatric population, improved diagnosis of patient, and increasing healthcare IT initiatives. Moreover, increasing prevalence of chronic diseases, increasing emphasis on care quality and patient safety, and increasing need to reduce healthcare costs through a connected healthcare environment are supporting the demand of medical device connectivity. The medical device connectivity aids in data analytics and growing adoption of telehealth solutions are also driving the growth of the market. Based on product type, the market for service segment is expected to grow at the faster rate compared to solution during the forecast period, due to increasing requirement for maximum consumption of connectivity solutions by the user, increasing regulatory requirements and healthcare reforms, increasing implementation of healthcare information exchange system, and increasing need for effective implementation.

Request to Get the Sample Report: https://www.psmarketresearch.com/market-analysis/medical-device-connectivity-market/report-sample

The growing adoption of telehealth solutions, shift of point-of-care diagnostics from hospitals to home care and increasing need for interoperability due to medical devices connectivity solutions are some of the major trends for the global medical device connectivity market.

Geographically, North America has been the largest and fastest growing market for medical device connectivity, owing to better accessibility to technologies, increasing demand for eHealth solutions, increasing funding for innovation in medical sector, increasing focus on quality of care and patient safety, and increasing government initiatives and support in the region. The U.S. contributed largest revenue to the North American as well as global medical device connectivity market. The increasing implementation of electronic health record systems, growing geriatric population, and increasing need for data analytic in healthcare are the key growth driving factor for the U.S. medical device connectivity market.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=medical-device-connectivity-market

The key players operating in the global medical device connectivity market are GE Healthcare, Cerner Corporation, Cisco Systems Inc., Qualcomm Inc., Koninklijke Philips N.V., Medtronic Plc., Infosys Limited, and Digi International Inc.

Patient Engagement Solutions Market: Market Trend and their Impact on Global Industry 2023

The global patient engagement solutions market is growing considerably, due to growing medical tourism and increasing cloud based models. During the forecast period, the software segment is expected to report the largest share, among all the components segments of the patient engagement solution market. Among the various delivery modes, the web based delivery segment leads the market, as it is cost effective and user friendly; however, the cloud based delivery segment is expected to grow with the fastest rate during the forecasted period. Among the various applications, the health management segment leads the global patient engagement solutions market. Based on therapeutics area, the chronic diseases segment leads the market in terms of size and is expected to grow with the fastest rate during the forecast period. Among the various end users, the providers segment led the market in 2014.

Request to Get the Sample Report: https://www.psmarketresearch.com/market-analysis/patient-engagement-solutions-market/report-sample

Geographically, North America is expected to dominate the global market in the coming years, due to growing geriatric population, implementation of Affordable Care Act, and increasing prevalence of chronic diseases. Asia is expected to be the fastest growing region, due to growing medical tourism and increasing healthcare awareness in the region. In addition, the Asian market of patient engagement solutions is growing due to increasing healthcare expenditure and increasing healthcare information technology adoption in the emerging countries, such as India and China.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=patient-engagement-solutions-market

Some of the companies operating in the global patient engagement solutions market are Mckesson Corporation, Athenahealth Inc., Medecision Inc., Cerner Corporation, Oneview healthcare, get Real Health, Welvu, Inc., Orion Health Ltd., Patientpoint, Lincor Solutions Ltd., EMMI Solutions LLC., Allscripts Healthcare Solutions Inc., Getwellnetwork Inc., and Phytel Inc.

Latin America Scar Treatment Market: Global Opportunity and Demand Analysis, Market Forecast, 2013-2023

The Latin America scar treatment market size was valued at $677.2 million in 2016, which is expected to attain $1,225.0 billion by 2023, growing at a CAGR of 8.9% during the forecast period (2017-2023). Topical scar treatment held the largest share of the market in 2016, ahead of surface, laser, injectable, and invasive surgical treatments. Scar treatment for keloid & hypertrophic scar is expected to witness the highest growth during forecast period in the regional market mainly due to increasing number of dermal injuries in the region.

Request to Get the Sample report: https://www.psmarketresearch.com/market-analysis/latin-america-scar-treatment-market/report-sample

The demand for scar treatment in Latin America has been growing, mainly due to increasing awareness and consciousness about appearance among people in the region. The growth in the region is expected to be concentrated around Brazil, due to increasing demand of scar treatment products in the country. Additionally, the disposable income in Brazil has been increasing, due to which the affordability for such procedures has also increased. It has been also observed that the number of aesthetic plastic surgeries performed in the country for various purposes, including scar treatment has also been increasing. According to the International Society of Aesthetic Plastic Surgery (ISAPS), 461,544 cosmetic surgeries were performed in Mexico in 2016, the third highest in the world after the U.S. and Brazil and 907,913 non-surgical procedures were performed in Mexico, the fourth highest in the world after the U.S., India and Brazil, thus driving the growth of the Latin America market.

Brazil’s medical tourism offers treatment and surgeries in aesthetic surgery thus, supporting the growth of the scar treatment market. With the increase in the volume of surgical and non-surgical aesthetic procedures in Latin America, the demand for various scar treatments is also expected to increase, thereby supporting the growth of the market.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=latin-america-scar-treatment-market

Some of the key players operating in the Latin America scar treatment market include Advanced Biotechnologies Inc., Scar Heal Inc., Silimed Inc., Natura Cosméticos S.A., Grupo Biomayan, Biodermis Cosmetics Ltd., GC Aesthetics PLC, Humco Holding Group, Inc., Farmoquimica S.A.

Asia-Pacific Scar Treatment Market by Revenue, Demand, Size and Growth Opportunities by 2023

The Asia-Pacific scar treatment market size was valued at $3.6 billion in 2016, which is forecasted to reach $7.8 billion by 2023, growing at a CAGR of 11.6% during the 2017-2023. Among the various types of scar treatments, topical scar treatment is expected to lead the scar treatment market in the region, followed by surface, laser, injectable, and invasive surgical treatment.  Increasing focus on personal well-being, rising awareness about scar treatments and growing availability of non-invasive and less expensive topical scar treatment products are expected to be the drive the demand for topical scar treatment products.

Request to Get the Sample Report: https://www.psmarketresearch.com/market-analysis/asia-pacific-scar-treatment-market/report-sample

The Asia-Pacific scar treatment market is expected to grow at a faster rate as compared to other regions, due to increasing focus of general population on personal well-being, rising disposable income and growing prevalence of skin related problems such as burns, wounds and increasing number of cosmetic procedures performed in the region. According to the WHO, approximately 1,000,000 people suffer from moderate or severe burns, every year. These burn cases may lead to scar formation, leading to increased demand for scar treatment products in the region. According to the International Society of Aesthetic Plastic Surgery (ISAPS), the cosmetic surgeries performed in countries such as South Korea and India, are increasing at a rapid rate. In 2015, total surgical procedures performed in South Korea was 445,144, and in India, the number stood at 420,454.

A. Menarini Asia-Pacific Holdings Pte. Ltd. offers Dermatix Ultra, a scar formula that uses the innovative CPX (cyclopentasiloxane) technology for improved effects in flattening and softening scars and holds Vitamin C providing photoprotection and skin lightening. With companies using innovative technologies for scar treatments, the demand for advanced scar treatment products is likely to increase during the forecast period.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=asia-pacific-scar-treatment-market

The key players operating in the Asia-Pacific scar treatment market include Shanghai Fosun Pharmaceutical (Group) Company Limited, Beijing Toplaser Technology Company Limited, Sirnaomics, Inc., Essex Bio-Technology Limited, A. Menarini Asia-Pacific Holdings Pte. Ltd, Shiseido Company Limited, Concord Medisys Pvt. Ltd, Seoulin Bioscience Co. Ltd., Hanson Medical Inc., Otsuka Pharmaceutical Co., Ltd.